C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2011
08/11/2011	WO2011054996A3 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus
08/11/2011	WO2011043809A9 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
08/11/2011	WO2011038394A3 Silk fibroin-decorin scaffolds
08/11/2011	WO2011026906A3 Novel microorganism and its use in lignocellulose detoxification
08/11/2011	WO2010149964A3 Mutant stabilised g- protein coupled receptors, their uses and methods producing them
08/11/2011	WO2010016069A9 A process for preparation of insulin compounds
08/11/2011	WO2006045308A8 Chlamydia trachomatis antigens for vaccine and diagnostic use
08/11/2011	US20110197314 Methods and Compositions for Controlling Plant Pests
08/11/2011	US20110197292 Delivery method
08/11/2011	US20110197291 Endoplasmic Reticulum Localization Signals
08/11/2011	US20110196180 Methods and compositions for producing olefins
08/11/2011	US20110196134 Process for PEGylation of Proteins
08/11/2011	US20110196133 Grifola-derived low-molecular-weight substance having immunopotentiating activity and antitumor activity
08/11/2011	US20110196130 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents
08/11/2011	US20110196128 Murine zcytor17 ligand polynucleotides
08/11/2011	US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins
08/11/2011	US20110195911 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
08/11/2011	US20110195908 Prosaposin as a neurotrophic factor
08/11/2011	US20110195905 Apls for treating arthritis
08/11/2011	US20110195901 Artery- and vein-specific proteins and uses therefor
08/11/2011	US20110195900 Peptidic pth receptor agonists
08/11/2011	US20110195897 Glycosylated glp-1 peptide
08/11/2011	US20110195896 Isoform-specific insulin analogues
08/11/2011	US20110195895 Fgf21 mutants and uses thereof
08/11/2011	US20110195892 Artifical Pulmonary Surfactant Compositions
08/11/2011	US20110195863 Loss of Function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits
08/11/2011	US20110195861 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
08/11/2011	US20110195510 csPCNA Isoform Modifications And Uses Thereof
08/11/2011	US20110195504 Tubulo-Vesicular Structure Localization Signals
08/11/2011	US20110195494 Dll4-binging molecules
08/11/2011	US20110195478 Bladder cancer biomarker and test method using the same
08/11/2011	US20110195453 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/11/2011	US20110195452 set of sequences for targeting expression and control of the post-translational modification of a recombinant polypeptide
08/11/2011	US20110195409 Streptococcus pyogenes classification
08/11/2011	US20110195407 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and uses of the same
08/11/2011	US20110195113 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
08/11/2011	US20110195112 Use of plant-derived recombinant growth factors in skin care
08/11/2011	US20110195089 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens
08/11/2011	US20110195084 Anti-HIV Vaccine Constructed Based on Amino Acid Mutations in Attenuated Live EIAV Vaccine
08/11/2011	US20110195083 Cyclic v3 peptides for anti hiv-1 vaccine
08/11/2011	US20110195078 Tat-based immunomodulatory compositions and methods for their discovery and use
08/11/2011	US20110195074 Ephrin Type-A Receptor 7 Protein
08/11/2011	US20110195072 Non-neuroendocrine cancer therapy
08/11/2011	US20110195068 Pd-1 antagonists and methods of use thereof
08/11/2011	US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS
08/11/2011	US20110195062 Mammalian Cytokines; Related Reagents and Methods
08/11/2011	US20110195048 Regulation of lymphocytes and uses therefor
08/11/2011	US20110195022 Cd20 antibodies and uses thereof
08/11/2011	US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer
08/11/2011	DE10121283B4 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen Methods and vectors for amplification or expression of the desired nucleic acid sequences in plants
08/11/2011	CA2789176A1 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains
08/11/2011	CA2789120A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis
08/11/2011	CA2789030A1 Template - fixed peptidomimetics with cxcr7 modulating activity
08/11/2011	CA2788993A1 Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
08/11/2011	CA2788902A1 Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
08/11/2011	CA2788560A1 Engineered cleavage half-domains
08/11/2011	CA2788547A1 Pharmaceutical composition for treating and/or preventing cancer
08/10/2011	EP2354793A2 Nucleic acids and proteins of insect OR83B odorant receptor genes and uses thereof
08/10/2011	EP2354791A1 Immunocytokines with modulated selectivity
08/10/2011	EP2354234A2 Gene promoters suitable for use in plants
08/10/2011	EP2354233A1 Pathogen inducible synthetic promoter
08/10/2011	EP2354230A1 Neisseria meningitidis surface protein
08/10/2011	EP2354159A1 CCL17 inhibitors for use in T helper cell-driven diseases
08/10/2011	EP2354157A1 Nucleic acids and proteins of insect OR83B odorant receptor genes and uses thereof
08/10/2011	EP2354156A2 Nucleic acids and proteins of insect OR83B odorant receptor genes and uses thereof
08/10/2011	EP2354155A2 Fusion Proteins for Treatment of CNS
08/10/2011	EP2354154A1 Recombinant methylated mycobacterial heparin-binding hemagglutinin antigen
08/10/2011	EP2354153A2 Stable peptide mimetic of HIV gp41 fusion intermediate
08/10/2011	EP2354149A1 Molecules with extended half-lives, compositions and uses thereof
08/10/2011	EP2353651A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders
08/10/2011	EP2353608A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
08/10/2011	EP2353389A1 Methods and compositions for treating disorders
08/10/2011	EP2353014A2 A screening assay for insecticides
08/10/2011	EP2353009A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies
08/10/2011	EP2352830A2 Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1
08/10/2011	EP2352761A2 Inhibition of plgf to treat philadelphia chromosome positive leukemia
08/10/2011	EP2352757A1 Proteases targeting agents
08/10/2011	EP2352756A1 High affinity t cell receptor and use thereof
08/10/2011	EP2352755A1 Diabetes t cell receptors
08/10/2011	EP2352754A1 Improved processing of recombinant human g-csf
08/10/2011	EP2352753A1 Biocidal fusion peptide comprising ll-37
08/10/2011	EP2352752A1 Transducible polypeptides for modifying mitochondrial metabolism
08/10/2011	EP2352751A2 Plasmodium vaccines, antigens, compositions and methods
08/10/2011	EP2352750A1 Buffers for controlling the ph of bone morphogenetic proteins
08/10/2011	EP2352749A1 Agent that modulates physiological condition of pests, involved in insect voltage-gated potassium channel activity
08/10/2011	EP2352748A1 Nitrogen responsive early nodulin gene
08/10/2011	EP2352747A1 Lawsonia intracellularis vaccines
08/10/2011	EP2352745A1 Antiviral polypeptides
08/10/2011	EP2352525A1 Somatostatin analogues
08/10/2011	EP2352515A1 Method for the treatment of hemophilia
08/10/2011	EP2352513A1 Treating diabetes melitus using insulin injections with less than daily injection frequency
08/10/2011	EP2352509A1 Hla-g proteins and pharmaceutical uses thereof
08/10/2011	EP2352508A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
08/10/2011	EP2352507A1 Peptidomimetic macrocycles with improved properties
08/10/2011	EP2029754B1 Magnetosome gene expression in eukaryotic cells
08/10/2011	EP1969004B1 Compositions comprising an acylated insulin and zinc and method of making the said compositions
08/10/2011	EP1893638B1 Insect-specific protease recognition sequences
08/10/2011	EP1709073B1 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
08/10/2011	EP1644513B1 Assay for detecting protein binding
08/10/2011	EP1572743B1 Peptides and their use for the treatment of hiv infections

1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 2916